174 related articles for article (PubMed ID: 18977806)
21. Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective.
Manchanda R; Menon U; Michaelson-Cohen R; Beller U; Jacobs I
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):31-8. PubMed ID: 19125001
[TBL] [Abstract][Full Text] [Related]
22. Biologic markers in endometrial cancer treatment.
Engelsen IB; Akslen LA; Salvesen HB
APMIS; 2009 Oct; 117(10):693-707. PubMed ID: 19775337
[TBL] [Abstract][Full Text] [Related]
23. Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.
Garg K; Soslow RA
J Clin Pathol; 2009 Aug; 62(8):679-84. PubMed ID: 19638537
[TBL] [Abstract][Full Text] [Related]
24. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
25. Alterations of the K-ras and p53 genes in Tamoxifen-associated endometrial carcinoma.
Fujiwara K; Enomoto T; Fujita M; Kanda T; Fujii S; Ito K; Wakasa K; Ishiko O; Ueda M; Yamaguchi S; Kimura T; Umesaki N
Oncol Rep; 2008 May; 19(5):1293-8. PubMed ID: 18425390
[TBL] [Abstract][Full Text] [Related]
26. Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma.
Jia L; Liu Y; Yi X; Miron A; Crum CP; Kong B; Zheng W
Clin Cancer Res; 2008 Apr; 14(8):2263-9. PubMed ID: 18369088
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of endometrial cancer and therapeutic implications.
Uppendahl L; Mullany SA; Winterhoff B
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):35-39. PubMed ID: 27941362
[TBL] [Abstract][Full Text] [Related]
28. Molecular bases of endometrial cancer: new roles for new actors in the diagnosis and the therapy of the disease.
Llauradó M; Ruiz A; Majem B; Ertekin T; Colás E; Pedrola N; Devis L; Rigau M; Sequeiros T; Montes M; Garcia M; Cabrera S; Gil-Moreno A; Xercavins J; Castellví J; Garcia A; Ramón y Cajal S; Moreno G; Alameda F; Vázquez-Levin M; Palacios J; Prat J; Doll A; Matías-Guiu X; Abal M; Reventós J
Mol Cell Endocrinol; 2012 Jul; 358(2):244-55. PubMed ID: 22037169
[TBL] [Abstract][Full Text] [Related]
29. Clinical, pathologic, and molecular features of early-onset colorectal carcinoma.
Yantiss RK; Goodarzi M; Zhou XK; Rennert H; Pirog EC; Banner BF; Chen YT
Am J Surg Pathol; 2009 Apr; 33(4):572-82. PubMed ID: 19047896
[TBL] [Abstract][Full Text] [Related]
30. The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies.
Bansal N; Yendluri V; Wenham RM
Cancer Control; 2009 Jan; 16(1):8-13. PubMed ID: 19078924
[TBL] [Abstract][Full Text] [Related]
31. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma.
Wu W; Lin Z; Zhuang Z; Liang X
Eur J Cancer Prev; 2009 Feb; 18(1):50-5. PubMed ID: 19077565
[TBL] [Abstract][Full Text] [Related]
32. [The premalignant disease of the endometrium: endometrial intraepithelial neoplasia].
Francz M
Magy Onkol; 2008 Mar; 52(1):35-40. PubMed ID: 18403295
[TBL] [Abstract][Full Text] [Related]
33. Mutation status of K-ras, p53 and allelic losses at 9p and 18q are not prognostic markers in patients with pancreatic cancer.
Salek C; Minarikova P; Benesova L; Nosek V; Strnad R; Zavoral M; Minarik M
Anticancer Res; 2009 May; 29(5):1803-10. PubMed ID: 19443408
[TBL] [Abstract][Full Text] [Related]
34. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis.
Castellvi J; Garcia A; Ruiz-Marcellan C; Hernández-Losa J; Peg V; Salcedo M; Gil-Moreno A; Ramon y Cajal S
Hum Pathol; 2009 Oct; 40(10):1418-26. PubMed ID: 19428047
[TBL] [Abstract][Full Text] [Related]
35. Do microsatellite instability profiles really differ between colorectal and endometrial tumors?
Ferreira AM; Westers H; Wu Y; Niessen RC; Olderode-Berends M; van der Sluis T; van der Zee AG; Hollema H; Kleibeuker JH; Sijmons RH; Hofstra RM
Genes Chromosomes Cancer; 2009 Jul; 48(7):552-7. PubMed ID: 19373783
[TBL] [Abstract][Full Text] [Related]
36. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
Cuatrecasas M; Catasus L; Palacios J; Prat J
Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
[TBL] [Abstract][Full Text] [Related]
37. Molecular profiling of endometrial malignancies.
Samarnthai N; Hall K; Yeh IT
Obstet Gynecol Int; 2010; 2010():162363. PubMed ID: 20368795
[TBL] [Abstract][Full Text] [Related]
38. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
39. Differential expression profiling of gene response to ionizing radiation in two endometrial cancer cell lines with distinct radiosensitivities.
Du XL; Jiang T; Wen ZQ; Li QS; Gao R; Wang F
Oncol Rep; 2009 Mar; 21(3):625-34. PubMed ID: 19212620
[TBL] [Abstract][Full Text] [Related]
40. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
